Prostacyclin deficiency in a young woman with recurrent thrombosis JOHN G LANHAM, MICHAEL LEVIN, ZARIN BROWN, AZZIZ E GHARAVI, PAUL A THOMAS, GILLIAN C HANSON Abstract A young woman with recurrent deep venous thromboses and spontaneous abortions was studied. She suffered an ovarian infarction followed by aortic thrombosis and renal failure. Evidence for deficient prostacyclin production was found and she responded to treatment with a prostacyclin infusion. This sypdrome is identical with that seen in women with the lupus anticoagulant, but the lupus anticoagulant was not detected and no other cause was identified.
Introduction
A syndrome of recurrent deep venous and arterial thromboses with recurrent spontaneous abortions has been described in young women with the lupus anticoagulant.' The lupus anticoagulant may be implicated in the pathogenesis of this syndrome through suppression of prostacyclin production. 23 We report a young woman with a similar syndrome, when life threatening arterial thrombosis occurred. No prostacyclin production by her own arterial tissue could be shown and reduced prostacyclin activity was found when umbilical cord artery and rat aortic tissue were incubated in her plasma. She did not have the lupus anticoagulant or any other disorder associated with arterial thrombosis. 
Case report
A 25 year old woman with no family history of thrombotic disease first took the oral contraceptive pill when aged 17, and six months later suffered bilateral deep vein thromboses and a pulmonary embolus. At the age of 23 she had a spontaneous abortion at eight weeks. One year later a second pregnancy was complicated by a left leg deep vein thrombosis at 26 weeks, and this pregnancy terminated with an intrauterine death at 31 weeks. Placental histology showed vascular insufficiency to be the cause.-A third pregnancy ended in spontaneous abortion at 24 weeks, despite treatment with subcutaneous heparin for the first 16 weeks followed by treatment with warfarin. Subcutaneous heparin (10000 units daily) was begun again after the abortion, but 10 days-later she developed a right iliofemoral vein thrombosis. The heparin dose was increased, but a fortnight thereafter she required a laparotomy because of a ruptured right tubo-ovarian cyst; histological examination showed infarcted ovarian and paraovarian tissues.
Three weeks later, while still receiving heparin, she presented with an ischaemic left foot with absent leg pulses and an abdominal aortic bruit. At emergency laparotomy thrombus was found in the aorta and both iliac and femoral arteries -(figure). This was removed and she was again fully heparinised. Postoperatively she developed acute renal failure and subsequently septicaemia and required ventilation. Her renal failure was attributed to extension of the thrombus into the renal arteries and a prostacyclin (epoprostenol) infusion was therefore begun. Thereafter, renal function improved rapidly as did perfusion of the right foot. The left foot remained ischaemic and was eventually amputated below the knee. On reduction of the dose of epoprostenol she developed severe bilateral leg oedema, which was ascribed to a partial inferior venacaval thrombosis. With an increased dose the oedema gradually subsided and the epoprostenol and heparin infusions were stopped a month later.
Treatment with warfarin, paediatric aspirin, and dipyridamole was started. Renal function returned to normal. At no time were there any clinical features to suggest a connective tissue disease or vasculitis.
Full blood count and erythrocyte sedimentation rate were normal during her third pregnancy but the platelet count rose from 250 to 640x 109/l at the time of the aortic thrombosis. Before treatment her prothrombin time and partial thromboplastin time were normal. To confirm that she did not have the lupus anticoagulant a plasma sample was fractionated and lupus anticoagulant activity was sought, but not found, in the IgG and IgM fractions (method of Boey et all). Fibrinogen, fibrinogen degradation products, and antithrombin III were also normal. Protein C concentration (chromogenic assay) was depressed but compatible with treatment with warfarin and did not suggest a congenital deficiency. No antibodies to nuclear antigens, deoxyribonucleic acid, extractable nuclear antigens, or cardiolipin were detected. Lipid concentrations were normal and screening for homocystinuria was negative. Histological examination of the aorta and tibial artery showed intraluminal thrombosis, but the vessel wall was normal, and no evidence of atheroma, vasculitis, or thrombotic thrombocytopenic purpura was found.
Arteriogra showing trmbus at aortlc bifulrcation, Prostacydlin production by arterga segments obtained fromn the amputated leg was assessed as described previously. Segments (2 cm long) of arterialrendotheliuim were cleared of subcutaneous tissue and kept iii ice cold saline buffered with phosphate for two hours until testing. These segments were incubated in both 500 1d ofher plasma and a similarquantity ofnora plasma for 15 minutes. An aliquot of 100 1i1 ofthe supeanatgnt wps removed amid added to 300 p1 of normal plasma rich in platelets. The mixture was challenged with 4~tmol adenosine diphosphate, and the amount of prostacyclin produced by the arterial segments was assessed by the degree of inhibition of platelet aggregation. No prostacyclin like activity was detected when the patient's arterial segments were incubated with either her own or normal plasma, whereas segments of artery taken from three other patients at necropsy and tested under comparable conditions produced prosta,cydlin. Further experixm,ents were performed by incubating the patient's plasma and that of the control with rings of aort from rats. ProstacycliLn production by rat aortic tissue ,was diminished on incubation with her plasma in comparisonwith control plasma. This returned tonormalafterherrecovery.
Her plasma was also shown to induce strong aggregation of normal washed platelets.
Discussion
Thrombosis of the distal aorta is rare. It has been re.ported in a few premenopausal women mn association with-pregnancy .and use of the oral contraceptive pill.5 Solitary atherosclerotic lesions have been found in some of these women and hea.vy smoking implicated as a predisposing factor.5 Aortic thrombosis has also been reported in the context of homocystinuria, antithrombmn III deficiency,-and vasculitisfr'
Young women with recurrent venous and arterial thrombosis and recurrent spontaneous abortion form a distinct subset of.patients, some of whom~have systemiic lupus erythematosus. -The .lupus anticoagulant is usually present mn this clinical setting and tests for anticardiolipi.n antibodies ar.e positive. The pathogenesis of this syndrome has yet to be established, but the favoured explanation implicates the lupus .anticoagulant as a suppressor o.f prostacyclin release.23 The lupus anticoagulant is an imunoglobulin, IgG, IgM, or both, that acts by inhibition of the phospholipid portion of the prothrombin activator complex. By bindling to these phospholipids it prolongs the partial thromboplastin time. Its binding to cardiolipin is responsible for the false positive tests for syphilis seen in patients with sytemic lupus erythematosus.9 The lupus anticoagulant is thought to inhibit prostacyclin production by interfering with the release of arachidonic acid (the substrate for prostacyclin) from phospholipids in the cell membrane. Prostacyclin is the most powerful known inhibitor-of platelet aggregation and a potent vasodilator and plays an important part in preventing thrombosis and maintaining placental blood flow." Inhibition of its release-by the lupus anticoagulant would explain the paradoxical association of the lupus anticoagulant with thrombotic disease as well as the tendency to spontaneous abortion. The disease in our patient closely resembled that seen in women with the lupus anticoagulant. We found no evidence, however, of the lupus anticoagulant or anticardiolipin antibodies. Nevertheless, we showed that her plasma failed to support prostacycin production when incubated with segments of rat aorta or human umbilical corid artery and that her arterial endotheli-um produced no prostacyclin. This suggests -a mechanism in our patient similar to that in patients with the lupus anticoagulant syndrome and implicates prostacyclin deficiency as a cause of her thrombotic events and spontaneous abortions.
Corticosteroid treatment ofpatients with the lupus anticoagulant syndrome has recently resulted in several successful pregnancies.'2 In those who suffer recurrent venous thrombosis treatment with heparin and warfarin is usually effective. -But the successful treatment of our patient with epoprostenol when preventive treatment with heparin and warfarin had failed, suggests the use of this agent in other cases when this clinical syndrome is associated with arterial thrombosis or extensive venous thrombosis, even if the lupus anticoagulant is not detectable. 
